Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older
PHASE2
The purpose of this clinical study was to evaluate immune responses measuri...
Trial to Compare the Safety, Tolerability, and Efficacy of Influenza Virus Vaccine, (CAIV-T) With Inactivated, Influenza Vaccine, Trivalent, Types A & B, in Adults Aged 60 Years and Older Against Culture-confirmed Influenza
PHASE3
To demonstrate that the efficacy over a defined surveillance period against...
Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children
PHASE3
\- Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy o...
Status
Completed
Location
Department of Microbiology, Research Institute for Tropical Medicine
Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults
PHASE3
To perform a variety of assays on blood, serum, nasal wash samples and cell...